CPC A61K 31/495 (2013.01) [A61P 37/06 (2018.01)] | 4 Claims |
1. A method for treating or ameliorating cytokine release syndrome (CRS) that does not respond to tocilizumab, wherein the method comprises:
administering to a patient in need thereof an effective amount of a compound represented by the following formula II:
or a pharmaceutically acceptable salt thereof.
|